Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Frontiers in Oncology|July 12, 2017
Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus VirotherapyJie Yin, James M Markert, Jianmei W LeavenworthInternational Braz J Urol : Official Journal of the Brazilian Society of Urology|July 4, 2006
Bilateral metastatic renal hemangiopericytoma ten years after primary intracranial lesionLee N Hammontree, Kristopher Whitehead, James M MarkertAnesthesia and Analgesia|April 25, 2006
Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resectionThomas A Moore, James M Markert, Robert C KnowltonPlos One|March 22, 2014
Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cellsJames J Cody, James M Markert, Douglas R HurstJournal of Neuro-Oncology|December 20, 2003
Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomasAmish C Shah, Dale Benos, G Yancey Gillespie, et al.CNS Oncology|November 21, 2022
Undesired impact of iron supplement on MRI assessment of post-treatment glioblastomaDahye Park, Mina Lobbous, Louis B Nabors, et al.Neurosurgery|April 8, 2011
Meta-analysis of hemorrhagic complications from ventriculostomy placement by neurosurgeonsDavid F Bauer, Shantanu N Razdan, Alfred A Bartolucci, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Oncolytic viral therapy of malignant gliomaJacqueline Nuss Parker, David F Bauer, James J Cody, et al.Advances in Virology|July 26, 2012
Human herpesviridae methods of natural killer cell evasionCarl I Odom, David C Gaston, James M Markert, et al.Oncolytic Virotherapy|August 12, 2016
Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapyThomas R Whisenhunt, Kiran F Rajneesh, James R Hackney, et al.Pageof 14